CASI Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Related People
Fund Service Providers
Startup & Company Raises
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
CASI Pharmaceuticals, Inc.
CIK #0001962738, 0000895051
EDGAR Form CIK 2011 - 2026
10-K [0000895051]
10-Q [0000895051]
3 [0000895051]
4 [0000895051]
8-K [0000895051]
D [0000895051]
SC 13D [0000895051]
SC 13G [0000895051]
3 [0001962738]
6-K [0001962738]
D [0001962738]
SC 13G [0001962738]
Form 13D/13G Filer Form 13D/13G Subject Filed
Chen Zhenfeng M CASI Pharmaceuticals Inc [2025-11-26]
Venrock Healthcare Capital Partners III LP CASI Pharmaceuticals Inc [2024-07-25]
Foresite Capital Fund VI LP CASI Pharmaceuticals Inc [2024-06-20]
Huang James CASI Pharmaceuticals Inc [2023-04-10]
Consonance Capital Management LP CASI Pharmaceuticals Inc [2021-02-17]
Consonance Capital Management LP CASI Pharmaceuticals Inc [2021-02-16]
Federated Hermes Inc CASI Pharmaceuticals Inc [2021-02-12]
Li Dapeng CASI Pharmaceuticals Inc [2019-02-06]
HE Wei-Wu CASI Pharmaceuticals Inc [2018-01-12]
Wealth Strategy Holding Ltd CASI Pharmaceuticals Inc [2017-12-01]
View All
Form 3/4/5 Subject 2011 - 2026
Folinsbee Thomas
CASI Pharmaceuticals, Inc.
Zeng Xuebo
Gao Wei R
Qian Kun
Huang Hai
Zukiwski Alexander A
Wang Chunhua
Krebs-Pohl Barbara Helene Hannelore
Wu Alex
View All
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com